Found 16 matching trials
A Study To Describe The Effect Of Impaired Hepatic Function Of The Pharmacokinetics Of Palbociclib PHASE1 This is a phase 1 study to describe the plasma pharmacokinetics of a single...
Show More Location
Orlando Clinical Research Center
Learn More & Join Trial
Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery PHASE2 This is a feasibility study which will evaluate the effects of pre-operativ...
Show More Location
MedStar Georgetown University Hospital
Learn More & Join Trial
Palbociclib in Combination With Fulvestrant Versus Fulvestrant in Advanced Breast Cancer: A Real-world Study in China N/A The purpose of this study is to evaluate efficacy and safety of CDK4/6 inhi...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer PHASE2 The trial consists of a series of parallel multi-centre single arm phase II...
Show More Location
Aberdeen Royal Infirmary
Learn More & Join Trial
HR+/HER2- Advanced Breast Cancer and Endocrine Resistance PHASE2 This is a randomized, 2-arm, open-label, multicenter, international phase I...
Show More Location
Sahlgrenska University Hospital
Learn More & Join Trial
Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer PHASE3 The primary objective of this study is to demonstrate that the combination ...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease PHASE3 The study is intended to show superiority of AZD9833 in combination with pa...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Palbociclib Plus Letrozole Treatment After Progression to Second Line Chemotherapy for Women With ER/PR-positive Ovarian Cancer PHASE2 The primary objective of this study is to evaluate 12 weeks progression-fre...
Show More Location
UFMG - Universidade Federal de Minas Gerais
Learn More & Join Trial
Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6) PHASE3 The study is intended to show superiority of AZD9833 in combination with CD...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer PHASE2 This clinical trial will assess the safety and early efficacy of Hydroxychl...
Show More Location
Georgetown University
Learn More & Join Trial